KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Deferred Revenue: 2015-2025

Historic Current Deferred Revenue for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $834.3 million.

  • Medpace Holdings' Current Deferred Revenue rose 24.35% to $834.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $834.3 million, marking a year-over-year increase of 24.35%. This contributed to the annual value of $710.6 million for FY2024, which is 26.92% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Current Deferred Revenue is $834.3 million, which was up 3.16% from $808.8 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Current Deferred Revenue ranged from a high of $834.3 million in Q3 2025 and a low of $277.8 million during Q1 2021.
  • In the last 3 years, Medpace Holdings' Current Deferred Revenue had a median value of $638.4 million in 2024 and averaged $639.4 million.
  • Data for Medpace Holdings' Current Deferred Revenue shows a peak YoY spiked of 49.97% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Medpace Holdings' Current Deferred Revenue stood at $344.6 million in 2021, then spiked by 34.26% to $462.7 million in 2022, then rose by 20.99% to $559.9 million in 2023, then increased by 26.92% to $710.6 million in 2024, then increased by 24.35% to $834.3 million in 2025.
  • Its last three reported values are $834.3 million in Q3 2025, $808.8 million for Q2 2025, and $718.7 million during Q1 2025.